Get the Stockscreener App
18.56
4.33%
-0.84
After Hours:
18.59
0.03
+0.16%
Enovis Corp stock is traded at $18.56, with a volume of 1.88M.
It is down -4.33% in the last 24 hours and down -39.86% over the past month.
Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.
See More
Previous Close:
$19.40
Open:
$19.01
24h Volume:
1.88M
Relative Volume:
1.56
Market Cap:
$1.07B
Revenue:
$2.28B
Net Income/Loss:
$-1.13B
P/E Ratio:
-0.9345
EPS:
-19.86
Net Cash Flow:
$35.92M
1W Performance:
-25.46%
1M Performance:
-39.86%
6M Performance:
-28.03%
1Y Performance:
-41.17%
1-Day Range:
$18.52
$19.32
1-Week Range:
$18.52
$24.87
52-Week Range:
$18.52
$34.28
Enovis Corp Stock (ENOV) Company Profile
Name
Enovis Corp
Sector
Industry
Phone
(302) 252-9160
Address
2711 CENTERVILLE ROAD, WILMINGTON
Compare ENOV vs ABT, MDT, SYK, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ENOV
Enovis Corp
|
18.56 | 1.51B | 2.28B | -1.13B | 35.92M | -19.86 |
ABT
Abbott Laboratories
|
108.33 | 197.51B | 46.59B | 5.41B | 7.38B | 3.0938 |
MDT
Medtronic Plc
|
94.17 | 118.14B | 36.36B | 4.84B | 5.43B | 3.7261 |
SYK
Stryker Corp
|
303.13 | 125.70B | 25.27B | 3.34B | 4.57B | 8.6334 |
BSX
Boston Scientific Corp
|
47.80 | 71.55B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.90 | 51.78B | 6.30B | 1.07B | 1.09B | 1.8406 |
Enovis Corp Stock (ENOV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-26 | Resumed | William Blair | Outperform |
| Jan-06-26 | Initiated | BTIG Research | Buy |
| Oct-03-24 | Initiated | JMP Securities | Mkt Outperform |
| Jun-13-24 | Initiated | JP Morgan | Neutral |
| Feb-13-24 | Initiated | Stephens | Overweight |
| Jan-22-24 | Initiated | UBS | Buy |
| Jan-03-24 | Initiated | William Blair | Outperform |
| Dec-15-23 | Reiterated | Needham | Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Jun-26-23 | Initiated | Needham | Buy |
| May-12-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Oct-11-22 | Initiated | Goldman | Buy |
| Sep-12-22 | Initiated | Canaccord Genuity | Buy |
| Sep-12-22 | Initiated | Evercore ISI | Outperform |
| Jun-28-22 | Initiated | Argus | Hold |
| Jun-27-22 | Resumed | Loop Capital | Buy |
| Jun-16-22 | Initiated | Wells Fargo | Equal Weight |
View All
Enovis Corp Stock (ENOV) Latest News
Enovis Stock (ENOV) Opinions on eCential Robotics Acquisition - Quiver Quantitative
Enovis to acquire surgical tech provider eCential Robotics for $180M - The Robot Report
Enovis Corp (ENOV) CEO Damien Mcdonald Purchases 13,035 Shares - GuruFocus
Enovis CEO McDonald buys $249,620 in Enov shares By Investing.com - Investing.com Australia
Enovis CAO Oliver Engert buys $149,970 in company stock - Investing.com
Enovis (NYSE: ENOV) CEO adds 13,035 shares in open-market buy - Stock Titan
Enovis CEO McDonald buys $249,620 in Enov shares - Investing.com
Enovis (NYSE: ENOV) executive buys 7,598 shares outside 10b5-1 plan - Stock Titan
Is Enovis Corp (ENOV) a Bargain After 4.3% Drop? GF Value Says U - GuruFocus
Enovis (ENOV) Stock Fair Value Falls As Analysts Weigh Robotics And Margin Pressure - Yahoo Finance
Enovis stock hits 52-week low at 19.12 USD By Investing.com - Investing.com South Africa
Enovis stock hits 52-week low at 19.12 USD - Investing.com
Citizens JMP Maintains Enovis Corp(ENOV.US) With Buy Rating, Cuts Target Price to $47 - Moomoo
Enovis Is Maintained at Buy by Freedom Capital Markets - Moomoo
Enovis Boosts Surgical Robotics Portfolio With eCential Acquisition - Yahoo Finance
ENOV Maintained by Citizens -- Price Target Lowered to $47.00 - GuruFocus
BMO cuts Enovis stock price target on margin headwinds from deal - Investing.com
Citizens lowers Enovis stock price target on robotics acquisition - Investing.com
Citizens lowers Enovis stock price target on robotics acquisition By Investing.com - Investing.com India
BMO Capital Adjusts Enovis Price Target to $27 From $30, Maintains Outperform Rating - Moomoo
Enovis to Acquire eCential Robotics for €155 Million in Surgical Robotics Deal - Minichart
Enovis to Acquire eCential Robotics for Up to €211 Million in Cash and Milestones - Kalkine Media
Enovis enters binding offer to acquire eCential Robotics By Investing.com - Investing.com Nigeria
ENOV Looks 45.5% Undervalued on GF Value™ Despite Profitability Challenges - GuruFocus
ENOV Looks 45.5% Undervalued on GF Value™ - GuruFocus
ENOV Looks 45.5% Undervalued on GF Value™ Amid Strategic Acquisi - GuruFocus
Enovis enters binding offer to acquire eCential Robotics - Investing.com
Enovis to Acquire eCential Robotics - marketscreener.com
Enovis to acquire eCential Robotics for €155 million By Investing.com - Investing.com Canada
Enovis to acquire eCential Robotics for up to €190 million - Investing.com
Enovis To Acquire eCential Robotics To Expand Surgical Robotics And ASTRA Enabling Technology Platform - Pulse 2.0
eCential Robotics Announces Binding Offer from Enovis - Financial Times
Enovis to acquire eCential Robotics for up to €190 million By Investing.com - Investing.com Nigeria
Enovis Invests in Innovation with Binding Offer to Acquire eCential Robotics, a Leading Developer of Enabling Technologies and Surgical Robotics - The Manila Times
Enovis Binding Offer: €155M Upfront Value for eCential | ENOV Stock News - Stock Titan
Enovis to Participate in the 2026 Wells Fargo Healthcare Conference - The Manila Times
Enovis Corporation: Arvis Is Disrupting The Healthcare Industry (NYSE:ENOV) - Seeking Alpha
Enovis: Executing Better, But Still Remains Stuck In A Med-Tech No Man’s Land (NYSE:ENOV) - Seeking Alpha
First National Bank of Omaha Makes New Investment in Enovis Corporation $ENOV - MarketBeat
Enovis (ENOV) Financial Update: Reported EPS Tops Expectations for the Current Session; Price Reaction - vinanet.vn
What Enovis (ENOV)'s Narrowing Losses And Reaffirmed 2026 Outlook Means For Shareholders - simplywall.st
Enovis (NYSE:ENOV) Stock Price Up 4.6%Here's Why - MarketBeat
Enovis Corporation (NYSE:ENOV) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ENOV Maintained by Canaccord Genuity -- Price Target Lowered to $45 - GuruFocus
Why Is Enovis (NYSE) a Stock to Track on the NYSE Index? - Kalkine Media
Canaccord Genuity Group Lowers Enovis (NYSE:ENOV) Price Target to $45.00 - MarketBeat
Rubric Capital discloses 3.9M-share Enovis (ENOV) position in Schedule 13G - Stock Titan
Enovis Corporation (ENOV) Stock Forecasts - Yahoo! Finance Canada
Can Enovis (ENOV) Narrowing Losses Without Strong Sales Growth Sustain Its Long-Term Strategy? - simplywall.st
Enovis Corp (ENOV) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Enovis (ENOV) Reaffirmed Guidance And Improved Margins, Is The Stock Still Undervalued? - simplywall.st
Enovis Corp Stock (ENOV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Enovis Corp Stock (ENOV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Engert Oliver | Chief Administrative Officer |
Jun 11 '26 |
Buy |
21.62 |
1,200 |
25,948 |
51,840 |
| Engert Oliver | Chief Administrative Officer |
Jun 10 '26 |
Buy |
23.00 |
1,000 |
23,000 |
50,640 |
| Engert Oliver | Chief Administrative Officer |
Jun 01 '26 |
Buy |
22.22 |
1,000 |
22,220 |
49,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 13 '26 |
Buy |
23.74 |
1,000 |
23,740 |
48,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 10 '26 |
Buy |
23.93 |
1,000 |
23,930 |
47,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 09 '26 |
Buy |
23.39 |
1,000 |
23,390 |
46,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 06 '26 |
Buy |
24.41 |
750 |
18,310 |
45,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 03 '26 |
Buy |
24.77 |
1,000 |
24,770 |
44,640 |
| Engert Oliver | Chief Administrative Officer |
Mar 04 '26 |
Buy |
25.10 |
250 |
6,275 |
44,890 |
| Engert Oliver | Chief Administrative Officer |
Feb 27 '26 |
Buy |
25.50 |
1,000 |
25,500 |
43,640 |
0.86%
0.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):